Mead Johnson Nutrition CO  

(Public, NYSE:MJN)   Watch this stock  
Find more results for MJN
72.08
-0.23 (-0.32%)
After Hours: 72.11 +0.03 (0.04%)
Aug 2, 6:06PM EDT  
NYSE real-time data - Disclaimer
Currency in USD
Range 71.48 - 72.50
52 week 60.62 - 88.72
Open 71.92
Vol / Avg. 1.20M/3.07M
Mkt cap 14.69B
P/E 26.35
Div/yield 0.30/1.66
EPS 2.74
Shares 203.76M
Beta 0.64
Inst. own 97%
Jul 26, 2012
Q2 2012 Mead Johnson Nutrition Earnings Conference Call - Webcast
Jun 19, 2012
Mead Johnson Nutrition at Deutsche Bank Global Consumer Conference - Webcast
More events from DailyFinance »    

Key stats and ratios

Q2 (Jun '12) 2011
Net profit margin 16.90% 14.11%
Operating margin 22.79% 19.63%
EBITD margin - 22.84%
Return on average assets 23.56% 20.51%
Return on average equity - -
Employees 6,600 -
Carbon Disclosure Rating - 14/100

Address

2701 Patriot Blvd.
GLENVIEW, IL 60026
United States - Map
+1-847-8322420 (Phone)
+1-302-6555049 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Discussion Group - Google Finance

Description

Mead Johnson Nutrition Company (Mead Johnson) is a global pediatric nutrition company. The Company manufactures, distributes and sells infant formulas, children's nutrition and other nutritional products. Its Enfa family of brands, including Enfamil infant formula, is the global brand franchise in pediatric nutrition. Its product portfolio addresses a range of nutritional needs for infants, children and expectant and nursing mothers. The Company markets its portfolio of more than 70 products to mothers, health care professionals and retailers in more than 50 countries in Asia, North America, Latin America and Europe. During the year ended December 31, 2011, it operated two segments: Asia/Latin America and North America/Europe, which consisted of 66% and 34%, respectively, of its net sales. In addition to the Enfa family of brands, the Company markets several other brands on a local, regional or global basis.

Officers and directors

Stephen W. Golsby President, Chief Executive Officer, Director
Age: 57
Bio & Compensation - Reuters
Peter G. Leemputte Chief Financial Officer, Executive Vice President
Age: 54
Bio & Compensation - Reuters
Peter Kasper Jakobsen President, Chief Executive Officer
Age: 50
Bio & Compensation - Reuters
William C. P'Pool Senior Vice President, General Counsel, Secretary
Age: 46
Bio & Compensation - Reuters
Lynn H. Clark Senior Vice President - Human Resources
Age: 54
Bio & Compensation - Reuters
Dirk Hondmann Ph.D. Senior Vice President - Global Research and Development
Age: 48
Bio & Compensation - Reuters
James Jeffrey Jobe Senior Vice President - Global Supply Chain
Age: 52
Bio & Compensation - Reuters
Charles M. Urbain Senior Vice President - Stakeholder Relations & Chief Development Officer
Age: 58
Bio & Compensation - Reuters
Stanley D. Burhans Vice President - Finance, Global Commercial Operations
Age: 45
Bio & Compensation - Reuters
Kathy A. MacDonald Vice President - Investor Relations, Acting Corporate Controller
Age: 48
Bio & Compensation - Reuters